PLA2 (group IIA phospholipase A2) as a prognostic determinant in stage II colorectal carcinoma (Q38422442)

2 September 2017

title

PLA2 (group IIA phospholipase A2) as a prognostic determinant in stage II colorectal carcinoma (English)

1 reference

2 September 2017

A Buhmeida

1

1 reference

2 September 2017

R Bendardaf

2

1 reference

2 September 2017

M Hilska

3

1 reference

2 September 2017

J Laine

4

1 reference

2 September 2017

Y Collan

5

1 reference

2 September 2017

M Laato

6

1 reference

2 September 2017

K Syrjänen

7

1 reference

2 September 2017

S Pyrhönen

8

1 reference

2 September 2017

publication date

10 March 2009

1 reference

2 September 2017

1 reference

2 September 2017

volume

20

1 reference

2 September 2017

issue

7

1 reference

2 September 2017

page(s)

1230-1235

1 reference

Loss of alleles from the distal short arm of chromosome 1 occurs late in melanoma tumor progression

2 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN783

Strain differences of rats in the susceptibility to aberrant crypt foci formation by 2-amino-1-methyl-6-phenylimidazo- [4,5-b]pyridine: no implication of Apc and Pla2g2a genetic polymorphisms in differential susceptibility

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN783

Lack of phospholipase A2 mutations in neuroblastoma, melanoma and colon-cancer cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN783

Distinct expression pattern of the full set of secreted phospholipases A2 in human colorectal adenocarcinomas: sPLA2-III as a biomarker candidate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN783

Expression of secretory phospholipase A2 in colon tumor cells potentiates tumor growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN783

Prognostic molecular markers for planning adjuvant chemotherapy trials in Dukes' B colorectal cancer patients: how much evidence is enough?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN783

Validation of tissue microarrays for immunohistochemical profiling of cancer specimens using the example of human fibroblastic tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN783

E-cadherin expression pattern in primary colorectal carcinomas and their metastases reflects disease outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN783

Increased group II phospholipase A2 in colonic mucosa of patients with Crohn's disease and ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN783

COX-2, Inflammatory Secreted PLA2, and Cytoplasmic PLA2 Protein Expression in Small Bowel Adenocarcinomas Compared with Colorectal Adenocarcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN783

Potential role of group X secretory phospholipase A(2) in cyclooxygenase-2-dependent PGE(2) formation during colon tumorigenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN783

Cytoplasmic phospholipase A2 expression in human colon adenocarcinoma is correlated with cyclooxygenase-2 expression and contributes to prostaglandin E2 production

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN783

Cytoplasmic phospholipase A2 alpha overexpression in stromal cells is correlated with angiogenesis in human colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN783

Thymidylate synthase and microsatellite instability in colorectal cancer: implications for disease free survival, treatment response and survival with metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN783

The effect of phospholipase A2 inhibitors on proliferation and apoptosis of murine intestinal cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN783

21 January 2018

Identifiers

DOI

10.1093/ANNONC/MDN783

1 reference

2 September 2017

1 reference